Literature DB >> 78298

Immune complexes in ovarian cancer.

T A Poulton, M E Crowther, F C Hay, L J Nineham.   

Abstract

Immune complexes have been assayed in ovarian cancer with a polyethylene-glycol (P.E.G.) precipitation assay and a Clq solid-phase assay. Significantly higher levels of immune complexes were detected in patients in relapse compared with those in remission. Remission values were within the range obtained for a control group. Evidence was produced that immune-complex levels rise before the clinical detection of relapse, and it is suggested that the P.E.G. assay could be a useful marker of disease progress.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 78298     DOI： 10.1016/s0140-6736(78)91383-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  19 in total

1.  Circulating immune complexes may play a regulatory and pathogenic role in experimental autoimmune uveoretinitis.

Authors:  E Kasp; M R Stanford; E Brown; A G Coombes; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Plasma exchange in systemic lupus erythematosus.

Authors:  H F Parry; C J Moran; M L Snaith; J D Richards; A H Goldstone; L J Nineham; F C Hay; W J Morrow; I M Roitt
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

3.  Victor Bonney Lecture, 1980. Ovarian cancer--a gynaecological disorder?

Authors:  C N Hudson
Journal:  Ann R Coll Surg Engl       Date:  1981-03       Impact factor: 1.891

4.  Activity of antibodies recovered from immune complexes of ovarian cancer patients.

Authors:  P M Lutz; J R Dawson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Neutrophil function in systemic lupus erythematosus and other collagen diseases.

Authors:  H Al-Hadithy; D A Isenberg; I E Addison; A H Goldstone; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

6.  The effects of amrinone on platelet count, survival and function in patients with congestive cardiac failure.

Authors:  P T Wilmshurst; S F Al-Hasani; M J Semple; A S Hamblin; P G Kioy; G F Lucas; G F Savidge; M M Webb-Peploe
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

7.  A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.

Authors:  N A Mooney; F C Hay; T A Poulton
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

8.  Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.

Authors:  T A Poulton; N A Mooney; L J Nineham; F C Hay
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

9.  Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.

Authors:  D P D'Cruz; F A Houssiau; G Ramirez; E Baguley; J McCutcheon; J Vianna; H J Haga; G T Swana; M A Khamashta; J C Taylor
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

10.  A study of anti-poly (ADP-ribose) antibodies and an anti-DNA antibody idiotype and other immunological abnormalities in lupus family members.

Authors:  C Dudeney; Y Shoenfeld; J Rauch; M Jones; C Mackworth Young; M Tavassoli; S Shall; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.